北美和欧洲数字治疗 (DTx) 市场 – 行业趋势和 2030 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Pharmaceutical North America And Europe Digital Therapeutics Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

北美和欧洲数字治疗 (DTx) 市场 – 行业趋势和 2030 年预测

  • Pharmaceutical
  • Published Report
  • Mar 2023
  • North America
  • 350 页面
  • 桌子數： 284
  • 图号： 59
立即购买 立即购买

北美和欧洲数字治疗 (DTx) 市场，按产品和服务类型（硬件产品、解决方案/软件和服务）、应用（治疗/护理相关应用和预防应用）、购买模式（团购组织和个人）、销售渠道（B2B 和 B2C）划分 - 行业趋势和预测到 2030 年。

北美和欧洲数字治疗 (DTx) 市场分析和见解

数字疗法 (DTx) 为患者提供基于证据的疗法，这些疗法由高质量的软件程序操作，用于预防、治疗或护理疾病。它们可单独使用或与药物、设备或其他疗法结合使用，以改善患者护理和健康状况。DTx 产品包含与设计、临床认证、可用性和数据安全相关的先进技术最佳应用。它们由立法机构根据需要验证，以支持有关风险、效力和预期使用的产品声明。DTx 为患者、医疗保健提供者和付款人提供可行的工具，通过高标准安全且几乎由数据驱动的药物来诊断各种疾病。

北美和欧洲数字治疗 (DTx) 市场北美和欧洲数字治疗 (DTx) 市场

一些市场参与者提供针对慢性病的产品和服务，这些产品和服务主要针对老年人口。在过去几年中，新的创新软件不断涌现，让人们更加依赖数字疗法。大量市场参与者参与提供服务以支持数字疗法，这为市场增长铺平了道路。

考虑到 DTx 行业产品的多样性，单个数字疗法有可能为患者、临床医生和付款人提供未满足的医疗需求的新型治疗选择，可以单独使用或与其他疗法结合使用，增强、支持或优化当前的医疗治疗，融入医疗指南和最佳实践，并能够在传统诊所环境之外扩展护理。

发达国家和发展中国家对数字治疗 (DTx) 的需求都在增加，其背后的原因是全球慢性病患病率的上升。由于政府机构意识的提高和医疗保健技术的进步，北美和欧洲的数字治疗 (DTx) 市场正在增长。随着数字治疗和技术进步的不断采用，预测期内市场将增长。

与患者信息有关的隐私政策、不可接受的数字支付选项以及欠发达国家缺乏互联网设施预计将抑制北美和欧洲数字治疗 (DTx) 市场的增长。

北美和欧洲数字治疗 (DTx) 市场具有支持性，旨在减缓疾病的进展。Data Bridge Market Research 分析称，在 2023 年至 2030 年的预测期内，北美和欧洲数字治疗 (DTx) 市场将以 24.8% 的复合年增长率增长，欧洲将以 23.53% 的复合年增长率增长。

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021 (可定制为 2015-2020)

定量单位

收入（百万美元），定价（美元）

涵盖的领域

按产品和服务类型（硬件产品、解决方案/软件和服务）、应用（治疗/护理相关应用和预防应用）、购买模式（团购组织和个人）、销售渠道（B2B 和 B2C）

覆盖国家

美国、加拿大、墨西哥、德国、英国、法国、意大利、西班牙、荷兰、俄罗斯、瑞士、土耳其、比利时和欧洲其他地区

涵盖的市场参与者

Noom（美国）、Atentiv（美国）、Cognoa（美国）、Kaia Health（美国）、Ginger（美国）、Livongo Health（美国）、Mango Health（美国）、Natural Cycles（瑞典）、Cognifit（美国）、Fitbit, Inc.（美国）、Omada Health Propeller Health（美国）、Welldoc, Inc.（美国）、Smart Patient GMBH（德国）、Mindstrong Health（美国）、Ayogo Health（加拿大）、Better Therapeutics（美国）、2morrow（美国）、Canary Health（美国）、Click Therapeutics（美国）、Pear Therapeutics（美国）、Voluntis（美国）、Akili Interactive Labs（美国）、三星（韩国）、Resmed（美国）和 GAIA AG（德国）等。

欧洲和北美数字治疗 (DTx) 市场动态

驱动程序

  • 慢性病患病率上升

糖尿病、高血压、哮喘等疾病的发病率不断上升，导致对数字治疗产品的需求不断增加。人们希望以最快捷、最简便的方式获得经济实惠且舒适的治疗方案。Digital Therapeutic 就是这样一个平台，它提供这些服务非常方便且用户友好。随着慢性病发病率的上升和对数字治疗的需求增加，该平台为患者提供了良好的服务。进步是必需的，数字治疗提供此类服务，这将有助于北美和欧洲数字治疗 (DTx) 市场的增长。

慢性病的流行是市场最强大的驱动因素。因此，预计这一情况将成为市场增长的驱动力。

  • 政府机构意识的提高

供应商、付款人和雇主对这些产品/服务提供的不同优势以及医疗保健成本的认识不断提高，这有助于推动市场增长。数字健康卓越中心 (DHCoE) 是设备和放射健康中心 (CDRH) 数字健康计划有组织发展的一部分，它已经与 FDA 以外的数字健康工作保持一致和协调。它注意到广泛采用数字健康技术的开始，为推广和掌握数字健康的可能性奠定了基础。

数字医学协会 (DiMe) 是一家由来自数字医学各个领域的专家组成的先锋专业公司。DiMe 的宗旨是促进数字医学发展，促进人类健康。他们提供的目的是交流和教育、研究和建设社区。这些战略有望成为市场增长的驱动力。

北美和欧洲数字治疗 (DTx) 市场

机会

  •  数字疗法需求不断增长

数字疗法的需求正在上升，因为它们提供以下功能：身心健康、预防、个人护理、分散护理和共同决策、长期状况处理以及紧急和急救护理的正确利用。

数字疗法提供最佳水平的医疗服务、跨所有级别的创新解决方案、支付方、受款人和社会可负担的医疗解决方案、医疗服务质量和解决方案结果清晰可见、以患者为中心、个性化以满足患者和员工的满意度，并且还可以根据提供的数据提供更快的诊断和行动，并通过教育、信息、授权、警报系统提供预防。因此，对数字疗法不断增长的需求有望成为市场增长的机遇。

限制

  • 患者信息隐私政策

隐私是数字治疗的主要障碍。人们更有兴趣通过传统医疗服务提供者接受治疗。这些应用程序需要患者不愿透露并希望保密的某些个人信息。因此，某些隐私因素会阻碍市场的增长。

此外，个人健康信息不再是私密的，这些应用程序会毫无顾忌地获取信息并将其分享给第三方，比如在社交媒体上发布广告。

因此，与数字治疗应用相关的隐私问题预计将成为市场增长的制约因素

挑战

  • 临床验证

公司需要获得临床验证才能将产品推向市场。在某些情况下，他们需要获得 FDA 的批准。这些程序需要很长时间，有时也不会产生积极的结果。

由于这些与数字疗法相关的临床研究需要时间才能完成，预计这将对市场构成挑战。

北美和欧洲数字治疗 (DTx) 市场报告提供了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。要获取有关数字治疗 (DTx) 市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报。我们的团队将帮助您做出明智的市场决策，以实现市场增长。

近期发展

  • 2023 年 1 月，Pear Therapeutics, Inc.（纳斯达克股票代码：PEAR）是一家开发和商业化基于软件的药物（称为处方数字疗法 (PDT)）的领导者，该公司宣布将其 PDT reSET® 和 reSET-O® 纳入 2023 年 1 月佛罗里达州医疗补助首选药物清单 (PDL)。reSET 和 reSET-O 是唯一获得 FDA 批准用于治疗物质使用障碍和阿片类药物使用障碍的 PDT，已于 2023 年 1 月 1 日起被添加到佛罗里达州医疗补助 PDL
  • 2022 年 12 月，Click Therapeutics, Inc.（以下简称“Click”）是 Digital Therapeutics™ 处方医疗治疗领域的领导者，该公司宣布其 CT-132 已获得美国食品药品管理局 (FDA) 颁发的突破性设备称号。Click 的 CT-132 处方数字疗法正在开发中，作为 18 岁及以上患者发作性偏头痛的辅助预防治疗

欧洲和北美数字治疗 (DTx) 市场细分

北美和欧洲数字治疗 (DTx) 市场分为四个重要细分市场，基于产品和服务类型、应用、购买模式和销售渠道。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

产品和服务类型

  • 硬件产品
  • 解决方案/软件
  • 服务

根据产品和服务类型，北美和欧洲数字治疗 (DTx) 市场分为硬件产品、解决方案/软件和服务。

按应用

  • 治疗/护理相关应用
  • 预防性应用

根据应用，北美和欧洲的数字治疗 (DTx) 市场分为治疗/护理相关应用和预防应用。

按购买方式

  • 团购组织
  • 个人

根据购买模式，北美和欧洲数字治疗（DTx）市场分为团购组织和个人。

按销售渠道

  • B2B
  • B2C

根据销售渠道，北美和欧洲数字治疗 (DTx) 市场分为 B2B 和 B2C。

北美和欧洲数字治疗 (DTx) 市场

数字治疗 (DTx) 市场区域分析/见解

对数字治疗 (DTx) 市场进行分析，并按国家、产品和服务类型、应用、购买模式和销售渠道提供市场规模洞察和趋势。

数字治疗 (DTx) 市场包括美国、加拿大、墨西哥、德国、英国、法国、意大利、西班牙、荷兰、俄罗斯、瑞士、土耳其、比利时和欧洲其他地区。

由于消费者对微藻健康益处的认识不断提高以及对微藻产品的需求增加，北美有望主导数字治疗 (DTx) 市场。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。数据点下游和上游价值链分析、技术趋势波特五力分析和案例研究是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。   

竞争格局和家庭医疗保健份额分析

北美和欧洲数字治疗 (DTx) 市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对继承的北美和欧洲数字治疗 (DTx) 市场的关注有关。

北美和欧洲数字治疗 (DTx) 市场的一些主要参与者包括：三星、Voluntis、Livongo、Fitbit, Inc.、ResMed、Natural Cycles USA Corp、GAIA AG、Smartpatient gmbh、Kaia Health、Pear Therapeutics Inc. 等。

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT AND SERVICE TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

5 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, INDUSTRY INSIGHT

CONCLUSION: 53

6 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, REGULATION

 

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES

7.1.2 INCREASE IN AWARENESS BY GOVERNMENT AGENCIES

7.1.3 TECHNOLOGICAL ADVANCEMENT IN HEALTHCARE

7.1.4 INCREASED NUMBER OF PEOPLE USING SMARTPHONES

7.1.5 IMPROVED QUALITY OF LIFE

7.2 RESTRAINTS

7.2.1 PATIENT INFORMATION PRIVACY POLICIES

7.2.2 DIGITAL PAYMENT ASSOCIATED WITH DIGITAL THERAPEUTICS

7.2.3 UNDERDEVELOPED COUNTRIES LACKING SMARTPHONES AND INTERNET FACILITIES

7.3 OPPORTUNITIES

7.3.1 RISING DEMAND FOR DIGITAL THERAPEUTICS

7.3.2 COLLABORATION BETWEEN COMPANIES TO PROVIDE BETTER PRODUCTS/SERVICES

7.3.3 PARTNERSHIP BETWEEN COMPANIES

7.3.4 EXPANSION AND LAUNCH OF PRODUCTS

7.3.5 EVENTS AND EXHIBITION

7.3.6 PHYSICIAN ADOPTION

7.4 CHALLENGES

7.4.1 CLINICAL VALIDATION

7.4.2 REGULATORY APPROVAL

7.4.3 PAYER REIMBURSEMENT

8 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE

8.1 OVERVIEW

8.2 SOLUTIONS/SOFTWARE

8.3 HARDWARE PRODUCTS

8.4 SERVICE

9 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 TREATMENT/CARE-RELATED APPLICATIONS

9.2.1 DIABETIS

9.2.1.1 TYPE 2

9.2.1.2 TYPE 1

 

9.2.2 CENTRAL NERVOUS SYSTEM DISORDERS

9.2.2.1 MENTAL HEALTH DISORDER

9.2.2.2 OTHER CNS DISORDERS

9.2.3 SMOKING CESSATION

9.2.4 CHRONIC RESPIRATORY DISEASES

9.2.4.1 ASTHMA

9.2.4.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE

9.2.4.3 OTHERS

9.2.5 CARDIOVASCULAR DISEASES

9.2.5.1 ARRHYTMIA

9.2.5.2 HEART FAILURE

9.2.5.3 OTHERS

9.2.6 MEDICATION ADHERENCE

9.2.7 ONCOLOGY

9.2.8 GASTROINTESTINAL DISORDERS

9.2.9 REHABILITATION & PATIENT CARE

9.2.10 SUBSTANCE USE DISORDERS & ADDICTION MANAGEMENT

9.2.11 OTHER TREATMENT/CARE-RELATED APPLICATIONS

9.3 PREVENTIVE APPLICATION

9.3.1 HEART ATTACKS

9.3.2 PREDIABETES

9.3.3 OBESITY

9.3.4 NUTRITION

9.3.5 LIFESTYLE MANAGEMENT

9.3.6 OTHER PREVENTIVE APPLICATIONS

10 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE

10.1 OVERVIEW

10.2 GROUP PURCHASE ORGANIZATION

10.3 SOLUTIONS/SOFTWARE

10.4 HARDWARE PRODUCTS

10.5 SERVICE

10.6 INDIVIDUAL

10.6.1 SOLUTIONS/SOFTWARE

10.6.2 HARDWARE PRODUCTS

10.6.3 SERVICE

 

11 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL

11.1 OVERVIEW

11.2 B2B

11.2.1 PAYERS

11.2.2 EMPLOYERS

11.2.3 PHARMACEUTICAL COMPANIES

11.2.4 PROVIDERS

11.2.5 OTHER BUYERS

11.3 B2C

11.3.1 CAREGIVERS

11.3.2 PATIENTS

12 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET

12.1 NORTH AMERICA

12.1.1 U.S.

12.1.2 CANADA

12.1.3 MEXICO

12.2 EUROPE

12.2.1 GERMANY

12.2.2 FRANCE

12.2.3 ITALY

12.2.4 U.K.

12.2.5 SPAIN

12.2.6 SWITZERLAND

12.2.7 IRELAND

12.2.8 NETHERLANDS

12.2.9 RUSSIA

12.2.10 HUNGARY

12.2.11 TURKEY

12.2.12 AUSTRIA

12.2.13 POLAND

12.2.14 NORWAY

12.2.15 LITHUANIA

12.2.16 REST OF EUROPE

13 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

13.2 COMPANY SHARE ANALYSIS: EUROPE

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 SAMSUNG

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 PRODUCT PORTFOLIO

15.1.4 RECENT DEVELOPMENT

15.2 VOLUNTIS

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 PRODUCT PORTFOLIO

15.2.4 RECENT DEVELOPMENT

15.3 NOOM, INC.

15.3.1 COMPANY SNAPSHOT

15.3.2 PRODUCT PORTFOLIO

15.3.3 RECENT DEVELOPMENT

15.4 FITBIT, INC.

15.4.1 COMPANY SNAPSHOT

15.4.2 PRODUCT PORTFOLIO

15.4.3 RECENT DEVELOPMENTS

15.5 LIVONGO

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 PRODUCT PORTFOLIO

15.5.4 RECENT DEVELOPMENT

15.6 AKILI INTERACTIVE LABS, INC.

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENTS

15.7 ATENTIV

15.7.1 COMPANY SNAPSHOT

15.7.2 PRODUCT PORTFOLIO

15.7.3 RECENT DEVELOPMENTS

15.8 AYOGO HEALTH INC.

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

 

15.9 BETTER THERAPEUTICS, INC

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENTS

15.1 CANARY HEALTH

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENT

15.11 COGNOA

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENTS

15.12 COGNIFIT

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENT

15.13 CLICK THERAPEUTICS, INC.

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENT

15.14 GINGER

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 GAIA AG

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 KAIA HEALTH

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENTS

15.17 MANGO HEALTH

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENT

15.18 MINDSTRONG HEALTH

15.18.1 COMPANY SNAPSHOT

15.18.2 PRODUCT PORTFOLIO

15.18.3 RECENT DEVELOPMENT

15.19 2MORROW INC.

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENTS

15.2 NATURAL CYCLES USA CORP

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENT

15.21 OMADA HEALTH, INC.

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENTS

15.22 PEAR THERAPEUTICS, INC.

15.22.1 COMPANY SNAPSHOT

15.22.2 PRODUCT PORTFOLIO

15.22.3 RECENT DEVELOPMENT

15.23 RESMED

15.23.1 COMPANY SNAPSHOT

15.23.2 REVENUE ANALYSIS

15.23.3 PRODUCT PORTFOLIO

15.23.4 RECENT DEVELOPMENT

15.24 SMARTPATIENT GMBH

15.24.1 COMPANY SNAPSHOT

15.24.2 PRODUCT PORTFOLIO

15.24.3 RECENT DEVELOPMENT

15.25 WELLDOC, INC.

15.25.1 COMPANY SNAPSHOT

15.25.2 PRODUCT PORTFOLIO

15.25.3 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

表格列表

TABLE 1 REGULATORY FRAMEWORK

TABLE 2 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 3 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 4 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 5 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 6 EUROPE TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 7 NORTH AMERICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 8 EUROPE DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 9 NORTH AMERICA DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 10 EUROPE CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 11 NORTH AMERICA CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 12 EUROPE CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 13 NORTH AMERICA CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 14 EUROPE CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 15 NORTH AMERICA CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 16 EUROPE PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 17 NORTH AMERICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 18 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 19 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 20 EUROPE GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 21 NORTH AMERICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 22 EUROPE INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 23 NORTH AMERICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 24 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 25 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 26 EUROPE B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 27 NORTH AMERICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 28 EUROPE B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 29 NORTH AMERICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 30 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 31 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 32 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 33 U.S. TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 34 U.S. CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 35 U.S. CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 36 U.S. CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 37 U.S. DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 38 U.S. PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 39 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 40 U.S. GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 41 U.S. INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 42 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 43 U.S. B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 44 U.S. B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 45 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 46 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 47 CANADA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 48 CANADA CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 49 CANADA CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 50 CANADA CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 51 CANADA DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 52 CANADA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 53 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 54 CANADA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 55 CANADA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 56 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 57 CANADA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 58 CANADA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 59 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 60 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 61 MEXICO TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 62 MEXICO CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 63 MEXICO CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 64 MEXICO CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 65 MEXICO DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 66 MEXICO PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 67 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 68 MEXICO GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 69 MEXICO INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 70 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 71 MEXICO B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 72 MEXICO B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 73 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 74 GERMANY DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 75 GERMANY DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 76 GERMANY TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 77 GERMANY CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 78 GERMANY CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 79 GERMANY CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 80 GERMANY DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 81 GERMANY PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 82 GERMANY DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 83 GERMANY GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 84 GERMANY INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 85 GERMANY DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 86 GERMANY B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 87 GERMANY B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 88 FRANCE DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 89 FRANCE DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 90 FRANCE TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 91 FRANCE CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 92 FRANCE CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 93 FRANCE CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 94 FRANCE DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 95 FRANCE PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 96 FRANCE DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 97 FRANCE GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 98 FRANCE INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 99 FRANCE DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 100 FRANCE B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 101 FRANCE B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 102 ITALY DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 103 ITALY DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 104 ITALY TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 105 ITALY CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 106 ITALY CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 107 ITALY CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 108 ITALY DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 109 ITALY PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 110 ITALY DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 111 ITALY GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 112 ITALY INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 113 ITALY DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 114 ITALY B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 115 ITALY B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 116 U.K. DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 117 U.K. DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 118 U.K. TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 119 U.K. CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 120 U.K. CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 121 U.K. CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 122 U.K. DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 123 U.K. PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 124 U.K. DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 125 U.K. GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 126 U.K. INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 127 U.K. DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 128 U.K. B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 129 U.K. B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 130 SPAIN DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 131 SPAIN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 132 SPAIN TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 133 SPAIN CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 134 SPAIN CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 135 SPAIN CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 136 SPAIN DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 137 SPAIN PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 138 SPAIN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 139 SPAIN GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 140 SPAIN INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 141 SPAIN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 142 SPAIN B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 143 SPAIN B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 144 SWITZERLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 145 SWITZERLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 146 SWITZERLAND TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 147 SWITZERLAND CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 148 SWITZERLAND CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 149 SWITZERLAND CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 150 SWITZERLAND DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 151 SWITZERLAND PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 152 SWITZERLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 153 SWITZERLAND GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 154 SWITZERLAND INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 155 SWITZERLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 156 SWITZERLAND B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 157 SWITZERLAND B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 158 IRELAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 159 IRELAND DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 160 IRELAND TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 161 IRELAND CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 162 IRELAND CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 163 IRELAND CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 164 IRELAND DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 165 IRELAND PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 166 IRELAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 167 IRELAND GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 168 IRELAND INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 169 IRELAND DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 170 IRELAND B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 171 IRELAND B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 172 NETHERLANDS DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 173 NETHERLANDS DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 174 NETHERLANDS TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 175 NETHERLANDS CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 176 NETHERLANDS CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 177 NETHERLANDS CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 178 NETHERLANDS DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 179 NETHERLANDS PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 180 NETHERLANDS DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 181 NETHERLANDS GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 182 NETHERLANDS INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 183 NETHERLANDS DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 184 NETHERLANDS B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 185 NETHERLANDS B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 186 RUSSIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 187 RUSSIA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 188 RUSSIA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 189 RUSSIA CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 190 RUSSIA CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 191 RUSSIA CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 192 RUSSIA DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 193 RUSSIA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 194 RUSSIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 195 RUSSIA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 196 RUSSIA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 197 RUSSIA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 198 RUSSIA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 199 RUSSIA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 200 HUNGARY DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 201 HUNGARY DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 202 HUNGARY TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 203 HUNGARY CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 204 HUNGARY CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 205 HUNGARY CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 206 HUNGARY DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 207 HUNGARY PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 208 HUNGARY DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 209 HUNGARY GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 210 HUNGARY INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 211 HUNGARY DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 212 HUNGARY B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 213 HUNGARY B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 214 TURKEY DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 215 TURKEY TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 216 TURKEY TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 217 TURKEY CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 218 TURKEY CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 219 TURKEY CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 220 TURKEY DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 221 TURKEY PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 222 TURKEY DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 223 TURKEY GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 224 TURKEY INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 225 TURKEY DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 226 TURKEY B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 227 TURKEY B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 228 AUSTRIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 229 AUSTRIA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 230 AUSTRIA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 231 AUSTRIA CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 232 AUSTRIA CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 233 AUSTRIA CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 234 AUSTRIA DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 235 AUSTRIA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 236 AUSTRIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 237 AUSTRIA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 238 AUSTRIA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 239 AUSTRIA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 240 AUSTRIA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 241 AUSTRIA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 242 POLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 243 POLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 244 POLAND TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 245 POLAND CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 246 POLAND CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 247 POLAND CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 248 POLAND DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 249 POLAND PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 250 POLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 251 POLAND GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 252 POLAND INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 253 POLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 254 POLAND B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 255 POLAND B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 256 NORWAY DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 257 NORWAY DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 258 NORWAY TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 259 NORWAY CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 260 NORWAY CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 261 NORWAY CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 262 NORWAY DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 263 NORWAY PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 264 NORWAY DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 265 NORWAY GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 266 NORWAY INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 267 NORWAY DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 268 NORWAY B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 269 NORWAY B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 270 LITHUANIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 271 LITHUANIA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 272 LITHUANIA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 273 LITHUANIA CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 274 LITHUANIA CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 275 LITHUANIA CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 276 LITHUANIA DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 277 LITHUANIA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 278 LITHUANIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 279 LITHUANIA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 280 LITHUANIA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION)

TABLE 281 LITHUANIA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 282 LITHUANIA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 283 LITHUANIA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION)

TABLE 284 REST OF EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION)

图片列表

FIGURE 1 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION

FIGURE 2 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: DROC ANALYSIS

FIGURE 4 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 10 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION

FIGURE 12 THE INCREASING DEMAND FOR DIGITAL THERAPEUTICS IS INCREASING WORLDWIDE DUE TO THE PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2030.

FIGURE 13 SOLUTIONS/ SOFTWARES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET IN 2023 & 2030

FIGURE 14 SOLUTIONS/ SOFTWARES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE DIGITAL THERAPEUTIC (DTX) MARKET IN 2023 & 2030

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET

FIGURE 16 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2022

FIGURE 17 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2023-2030 (USD MILLION)

FIGURE 18 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, CAGR (2023-2030)

FIGURE 19 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, LIFELINE CURVE

FIGURE 20 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2022

FIGURE 21 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2023-2030 (USD MILLION)

FIGURE 22 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, CAGR (2023-2030)

FIGURE 23 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, LIFELINE CURVE

FIGURE 24 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2022

FIGURE 25 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 26 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 27 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 28 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2022

FIGURE 29 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 30 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 31 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 32 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2022

FIGURE 33 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2023-2030 (USD MILLION)

FIGURE 34 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, CAGR (2023-2030)

FIGURE 35 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, LIFELINE CURVE

FIGURE 36 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2022

FIGURE 37 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2023-2030 (USD MILLION)

FIGURE 38 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, CAGR (2023-2030)

FIGURE 39 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, LIFELINE CURVE

FIGURE 40 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2022

FIGURE 41 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2023-2030 (USD MILLION)

FIGURE 42 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, CAGR (2023-2030)

FIGURE 43 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, LIFELINE CURVE

FIGURE 44 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2022

FIGURE 45 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2023-2030 (USD MILLION)

FIGURE 46 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, CAGR (2023-2030)

FIGURE 47 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, LIFELINE CURVE

FIGURE 48 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SNAPSHOT (2022)

FIGURE 49 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2022)

FIGURE 50 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2023 & 2030)

FIGURE 51 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2022 & 2030)

FIGURE 52 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: PRODUCT AND SERVICE TYPE (2023-2030)

FIGURE 53 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: SNAPSHOT (2022)

FIGURE 54 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2022)

FIGURE 55 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2023 & 2030)

FIGURE 56 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2022 & 2030)

FIGURE 57 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: PRODUCT AND SERVICE TYPE (2023-2030)

FIGURE 58 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY SHARE 2022 (%)

FIGURE 59 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY SHARE 2022 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The North America and Europe Digital Therapeutic (DTx) Market will grow at a CAGR of 24.8% in North America and 23.53% in Europe during the forecast period by 2030
The North America and Europe Digital Therapeutic (DTx) Market is segmented on the basis of product and service type, application, purchase mode and sales channel.
The major players in the North America and Europe Digital Therapeutic (DTx) Market are Noom(U.S.), Atentiv(U.S.), Cognoa(U.S.), Kaia Health(U.S.), Ginger(U.S.), Livongo Health(U.S.), Mango Health(U.S.), Natural Cycles (Sweden), Cognifit (U.S.), Fitbit, Inc.(U.S.), Omada Health Propeller Health(U.S.), etc.
The countries covered in the North America and Europe Digital Therapeutic (DTx) Market are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, and the Rest of Europe.

浏览相关页面

Banner